In two studies, semaglutide failed to slow decline in thousands of people with early stages of Alzheimer's disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback